CNDSN3 month 31 days [] (Department of Commerce) in March 31, 2015, the State Ministry of commercewebsite officially announced Shandong Frieda pharmaceutical group company won the direct selling license.

Company introduction:

Shandong Furuida Pharmaceutical Group Company was founded in April 17, 1993, formerly known asbiochemical pharmaceutical company in Shandong Province, belongs to Shandong Commercial Group Co.,Ltd., is a collection of science, industry and trade in one of the modern large-scale high-tech industry group.Shandong Furuida Pharmaceutical Group Company in Shandong Province Pharmaceutical Sciences for technical support, product development based on the associated with human health drugs, health food andcosmetics, forming a science, industry and trade integration of comprehensive pharmaceutical enterprise group. Pharmaceutical group with its own intellectual property rights of technology has set up (Yuan Zhengda) Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd, Shandong Freda BiologicalPharmaceutical Co. Ltd., Shandong Akihito Freda Pharmaceutical Co. Ltd, Shandong Freda BiologicalEngineering Co., Ltd, Shandong Freda Biological Technology Co., Ltd. and a number of high-tech enterprises. Industry relates to medicine, health food, cosmetics, medical equipment and raw materials, has the "Shu", "Run Jie", "Sofast", "Akihito", "Yi Lin" and other well-known brands. Freda Pharmaceutical Groupin 2011 sales revenue 1730000000 yuan, profits and taxes 368000000 yuan. Which Shandong Bausch & Lomb Freda Pharmaceutical Co. Ltd has grown into the largest department of Ophthalmology drugsdomestic production base, the product has to occupy the domestic market share of 20% drugs in the Department of ophthalmology. The technical advantages of Shandong Freda Biological Pharmaceutical Co. Ltd. by virtue of fermentation production of hyaluronic acid, its products not only in the domestic market to occupy a major share of the market, but also exported to Japan, the United States, Europe, South Koreaand other international markets. *

Editor: small Shen